The effect of mirabegron, a potent and selective β₃-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol

By Krauwinkel Walter   Dickinson James   Schaddelee Marloes   Meijer John   Tretter Reiner   Wetering Jeroen   Strabach Gregory   Gelderen Marcel  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Terminalia arjuna on Experimental Hyperlipidemia in Rabbits

By Shaila H.P.   Udupa S.L.   Udupa A.L.   Nair N.S.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 35, Iss. 2, 1997-04 ,pp. : 126-129

Informa Healthcare

Access to resources Recommend Favorite

Influence of CYP2C9 and CYP2D6 Polymorphisms on the Pharmacokinetics of Nateglinide in Genotyped Healthy Volunteers

By Kirchheiner J.  

Clinical Pharmacokinetics, Vol. 43, Iss. 4, 2004-01 ,pp. : 267-278

Adis International

Access to resources Recommend Favorite

Hypocholesterolaemic Activity in Rats of Different Fractions from Terminalia arjuna

By Shaila H.P.   Udupa S.L.   Udupa A.L.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 7, 2000-07 ,pp. : 327-330

Pharmaceutical Press

Access to resources Recommend Favorite

Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models

By Babu P. Ravindra  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 6, 2013-06 ,pp. : 873-879

Informa Healthcare

Access to resources Recommend Favorite